| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP and Chief Medical Officer
1 company
Smith Thomas B is an EVP and Chief Medical Officer at COLL. Recent filings cover 0 purchases and 3 sales. Those positions are worth an estimated $4.2M at current prices.
Our model assigns Smith Thomas B a middling insider score of 60/100, based on 3 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +10.7%.
Smith Thomas B's largest disclosed position is in COLL as EVP and Chief Medical Officer, worth about $4.2M. The recent filings there lean toward selling, a net 28,066 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2025 | COLL Collegium Pharmaceutical, Inc | EVP and Chief Medical Officer | Sell | 17,478 | $38.42 | $671,576.42 | -19.9% | +20.3% | -34.7% | |
| Sep 13, 2024 | COLL Collegium Pharmaceutical, Inc | EVP and Chief Medical Officer | Sell | 9,593 | $36.62 | $351,319.64 | -15.1% | -19.8% | -0.5% | |
| Feb 29, 2024 | COLL Collegium Pharmaceutical, Inc | EVP and Chief Medical Officer | Sell | 995 | $36.76 | $36,580.18 | -1.5% | -9.6% | -20.9% |